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ABSTRACT
Background Most of the data regarding the burden of
hypertension in low-income and middle-income countries
comes from cross-sectional surveys instead of
longitudinal studies. We estimated the incidence of, and
risk factors for, hypertension in four study sites with
different degree of urbanisation and altitude.
Methods Data from the CRONICAS Cohort Study,
conducted in urban, semiurban and rural areas in Peru,
was used. An age-stratiﬁed and sex-stratiﬁed random
sample of participants was taken from the most updated
census available in each site. Hypertension was deﬁned
as systolic blood pressure ≥140 mm Hg, or diastolic
blood pressure ≥90 mm Hg, or self-report physician
diagnosis and current treatment. The exposures were
study site and altitude as well as modiﬁable risk factors.
Incidence, incidence rate ratios (IRRs), 95% CIs and
population-attributable fractions (PAFs) were estimated
using generalised linear models.
Results Information from 3237 participants, mean age
55.8 (SD±12.7) years, 48.4% males, was analysed.
Overall baseline prevalence of hypertension was 19.7%
(95% CI 18.4% to 21.1%). A total of 375 new cases of
hypertension were recorded, including 5266 person-years
of follow-up, with an incidence of 7.12 (95% CI 6.44 to
7.88) per 100 person-years. Individuals from semiurban
site were at higher risk of hypertension compared with
highly urbanised areas (IRR=1.76; 95% CI 1.39 to
2.23); however, those from high-altitude sites had a
reduced risk (IRR=0.74; 95% CI 0.58 to 0.95). Obesity
was the leading risk factor for hypertension with a great
variation according to study site with PAF ranging from
12.5% to 42.4%.
Conclusions Our results suggest heterogeneity in the
progression towards hypertension depending on
urbanisation and site altitude.
INTRODUCTION
Worldwide, the increasing number of cases of
hypertension is mainly attributed to population
growth, ageing and modiﬁable risk factors. The
design of population-wide and individual strategies
to prevent hypertension depends on the availability
of reliable information.1 2 However, most of the
available data regarding the contribution of risk
factors to the burden of hypertension in low/
middle-income countries (LMICs) come from
cross-sectional surveys instead of longitudinal pro-
spective studies.
Urbanisation can negatively affect population
health due to changes in diet and physical activity
patterns,3 4 with a subsequent increase on cardiovas-
cular disease. In a previous cross-sectional study in
Peru,5 a high degree of geographical variation was
observed in the prevalence and distribution of risk
factors for raised blood pressure. Peru, a
middle-income country where more than half of all
causes of deaths are due to non-communicable dis-
eases,6 is characterised by the coexistence of urban,
semiurban and rural settings, as well as high-altitude
and low-altitude areas, providing thus a unique
scenario to assess how urbanisation and altitude
may impact, using a longitudinal approach, on the
incidence of hypertension.
This study aimed to estimate the incidence of,
and risk factors for, hypertension in four study sites
with different degree of urbanisation and altitude
in Peru. Besides, the overall and site-speciﬁc impact
of modiﬁable risk factors on hypertension rates was
assessed and population-attributable fractions
(PAFs) were estimated.
METHODS
Study design
Details about the CRONICAS Cohort Study have
been published elsewhere.7 Brieﬂy, this is an
ongoing prospective cohort study conducted in four
resource-limited settings in Peru featuring geo-
graphic differences: highly urbanised Lima and
semiurban Tumbes, both at sea level, and urban and
rural Puno at 3825 m above sea level. Information
from the ﬁrst two follow-up assessments, on average
15 and 30 months after baseline, was analysed.
Study population
A random sample of participants stratiﬁed by age
(35–44, 45–54, 55–64 and 65+ years) and sex was
taken from the most updated census available in
each study site. In each study site, 1000 individuals
were enrolled; in Puno, however, 500 subjects were
recruited in each urban and rural area. Individuals
aged ≥35 years were eligible for the study, and only
one person was recruited per household. Exclusion
criteria included pregnant women, those who could
not provide informed consent, were unable to
respond to the questionnaires or were bedridden.7
Variables deﬁnition
The main outcome of interest was the development
of hypertension: systolic blood pressure (SBP)
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≥140 mm Hg, or diastolic blood pressure (DBP) ≥90 mm Hg,8
or self-report physician diagnosis and currently receiving treat-
ment for hypertension. Similarly, this deﬁnition was used to
assess hypertension status at baseline (prevalence). Besides, SBP
and DBP were also assessed as continuous variables. At baseline
and follow-up evaluations, blood pressure was measured in trip-
licate after a 5 min resting period using an automatic monitor
OMRON HEM-780 (OMRON, Tokyo, Japan) previously vali-
dated for adult population.9 Additionally, prehypertension was
deﬁned as an SBP from 120 to 139 mm Hg or DBP from 80 to
89 mm Hg without any treatment. Data about self-report phys-
ician diagnosis and current antihypertensive treatment were col-
lected using standardised questionnaires applied by trained
ﬁeldworkers.
The exposure of interest was geographical variation assessed as
urbanisation (highly urbanised Lima, urban Puno, semiurban
Tumbes and rural Puno) and altitude (low-altitude vs high-altitude
study sites). Modiﬁable risk factors assessed at baseline were also
evaluated: daily smoking at least one cigarette per day (no/yes),
self-reported; heavy alcohol drinking, deﬁned as having had >1
night of alcohol intake in the previous month and having had
drunk ≥6 drinks at the same time (no/yes); number of hours of TV
watching per day (<2 and ≥2 hours per day), self-reported;10 11
physical inactivity based on the leisure-time and transport-related
domains of the International Physical Activity Questionnaire
(IPAQ):12 leisure-time inactivity was deﬁned as doing none or very
little physical activity (ie, <600 MET-min/week) during leisure
time, whereas transport-related inactivity was deﬁned as not
reporting walking or cycling trips (ie, a single walk or cycle trip for
≥10 min was considered to be classiﬁed as physically active);13
and fried food and high-sugar beverage consumption, both
assessed separately with a frequency questionnaire with potential
responses split into two categories (less than weekly vs weekly/
daily). All these variables were assessed at baseline.
Additionally, other risk factors, based on anthropometric mea-
surements, were assessed at baseline: body mass index (<25,
25–29.9 and ≥30 kg/m2);14 central obesity, based on waist cir-
cumference and categorised according to current guidelines for
our population (<80 and ≥80 cm for females, and <90 and
≥90 cm for males);15 fasting total cholesterol (<200 and
≥200 mg/dL);16 metabolic syndrome, based on the joint scien-
tiﬁc statement;15 and type 2 diabetes mellitus, deﬁned as any of
the following conditions: fasting glucose ≥126 mg/dL or self-
report of physician diagnosis and currently receiving antihyper-
glycaemic drugs.17 Total cholesterol was measured on serum,
whereas glucose was measured in plasma using an enzymatic
colorimetric method (GOD-PAP; Modular P-E/Roche-Cobas,
Grenzach-Whylen, Germany).
Other variables assessed at baseline and included in the ana-
lysis were sex (female or male); age (35–44, 45–54, 55–64 and
≥65 years); education (<7, 7–11 and ≥12 years) and socio-
economic status, assessed using a wealth index indicator based
on assets and household facilities, and split in tertiles (low,
middle and high).
Procedures
Fieldwork activities have been published elsewhere.7 In brief, at
baseline, ﬁeldworkers visited households to contact potential
participants and enrol them in the study. Subjects responded to
a face-to-face questionnaire applied by trained community
health workers using paper-based formats. After completing the
questionnaire, an appointment for clinical evaluation was agreed
to guarantee adequate fasting period (8–12 hours). A total of
13.5 mL of blood was drawn at baseline for cholesterol and
glucose assessment. Standing height and abdominal circumfer-
ence, in triplicate, was measured using standardised techniques.
Weight was assessed using the TBF-300A body composition ana-
lyzer (TANITA Corporation, Tokyo, Japan).
Statistical analysis
All the analyses were conducted using Stata V.13.0 for Windows
(StataCorp, College Station, Texas, USA). Initially, a description
of the study population was performed according to study site
characteristics (urbanisation and altitude).
As incidence allows us to compare progression towards non-
communicable conditions among populations, overall incidence rate
of hypertension was estimated after excluding subjects with hyper-
tension at baseline and reported per 100 person-years of follow-up.
Incidence rates were also estimated according to population
characteristics. The risk of developing hypertension according to
study site and altitude was assessed using generalised linear models,
assuming Poisson distribution, log-link function and including
robust SEs. Crude and adjusted models were estimated controlling
for different sociodemographic, behavioural and anthropometric
confounders, reporting incidence rate ratios (IRRs) and their 95%
CIs. Given the number of confounders and the potential correlation
between them, the variance inﬂation factor was used to determine
collinearity and exclude high correlated variables from the model if
needed. Risk factors were also evaluated using the same strategy:
adjusted models included age, sex, education level, socioeconomic
status and study site as confounders. Overall and site-speciﬁc regres-
sion models were created to estimate IRRs, and PAFs were calcu-
lated using the punaf command in STATA.18
Differences in SBP and DBP variation, in mm Hg, during
follow-up rounds were assessed for each exposure using
repeated measures analysis of variance excluding participants
with hypertension at baseline. In addition, random intercept
models including two levels (assessments as level 1 units and
subjects as level 2 clusters) were ﬁtted. The crude model
included the exposure of interest and the time of follow-up as
categorical variable (baseline, 15 months and 30 months),
whereas the adjusted models included, in addition, some poten-
tial confounders. Regression model results are presented as coef-
ﬁcients with their respective 95% CI.
RESULTS
Characteristics of the study population and baseline
prevalence of hypertension
A total of 3237 participants were enrolled at baseline, mean age
55.8 (SD 12.7) years and 1565 (48.4%) were males.
Characteristics and risk factor proﬁles of the study population,
by site characteristics and hypertension status at baseline, are
presented in Table 1 and online supplementary eTable 1,
respectively. The prevalence of hypertension at baseline was
19.7% (95% CI 18.4% to 21.1%), whereas prehypertension
was present in 24.9% (95% CI 23.4% to 26.4%).
Incidence of hypertension and change of blood pressure
levels
Of the total subjects evaluated at baseline, 196 (6.1%) were lost
to follow-up, 38 (1.2%) died during follow-up and 641
(19.7%) were further excluded from incidence calculations
because of their hypertension diagnosis at baseline. Among
those lost to follow-up, 17.7% were from Lima, 43.7% were
from urban Puno, 7.6% were from semiurban Tumbes and
31.0% were from rural Puno. Therefore, data from 2362
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subjects were used in incidence estimations. Mean time of
follow-up was 2.4 (SD 0.4) years, completing a total of 5266
person-years of follow-up. A total of 375 new cases of hyper-
tension were found with an overall incidence of 7.12 (95% CI
6.44 to 7.88) per 100 person-years. Hypertension incidence,
crude IRR and 95% CI according to population characteristics
are shown in online supplementary eTable 2.
SBP mean at baseline (year 2010), ﬁrst follow-up (at
15 months after baseline) and second follow-up (at 30 months
after baseline) were 111.6 (SD 12.6), 111.9 (SD 14.3) and
114.0 (SD 15.9) mm Hg, respectively (p<0.001). Changes in
DBP mean were from 70.7 (SD 8.5), 70.4 (SD 9.2) and 71.1
(SD 9.7) mm Hg in the same assessments (p=0.007).
Study site, modiﬁable factors and the risk of hypertension
The incidence of hypertension was high in semiurban Tumbes
compared with urbanised or rural study sites, and low in
high-altitude areas (table 2). After controlling by potential
confounders, individuals from semiurban Tumbes were at
higher risk of developing hypertension compared with sub-
jects from highly urbanised Lima (IRR=1.76; 95% CI 1.39 to
2.23), but there was no difference in the risk of hypertension
in the other sites. In addition, individuals from high-altitude
sites were at lower risk of hypertension (IRR=0.74; 95% CI
0.58 to 0.95).
In multivariable model, heavy alcohol drinking was the only
modiﬁable risk factor associated with increased risk of hyperten-
sion (IRR=1.88; 95% CI 1.31 to 2.69). Variables related to
obesity (body mass index, central obesity and metabolic syn-
drome) increased the risk of developing hypertension. PAF of
obesity-related variables were >20% (ﬁgure 1); nevertheless,
there was a wide variation between study sites: from 12.5% in
urban Puno to 42.4% in rural Puno. Individuals with type 2 dia-
betes mellitus and prehypertension were also at greater risk of
developing hypertension. However, the association between
exposures of interest and risk of hypertension varied according
to study site (see online supplementary eTable 3) and altitude
(see online supplementary eTable 4).
Table 1 Population characteristics according to urbanisation and altitude at baseline
Urbanisation Altitude
Lima Urban Puno Tumbes Rural Puno Low altitude High altitude
(n=1052) (n=574) (n=581) (n=1030) (n=2082) (n=1155)
Sociodemographics, n (%)
Sex
Female 546 (51.9%) 297 (51.7%) 311 (53.5%) 518 (50.3%) 1064 (51.1%) 608 (52.6%)
Age (years)
<45 248 (23.6%) 139 (24.2%) 128 (22.1%) 260 (25.2%) 508 (24.4%) 267 (23.2%)
45–54 286 (27.2%) 139 (24.2%) 148 (25.6%) 251 (24.4%) 537 (25.8%) 287 (24.9%)
55–64 264 (25.1%) 147 (25.6%) 148 (25.6%) 261 (25.3%) 525 (25.2%) 295 (25.6%)
65+ 254 (24.1%) 149 (26.0%) 155 (26.7%) 258 (25.1%) 512 (24.6%) 304 (26.4%)
Education level (years)
< 7 454 (43.2%) 91 (15.9%) 373 (64.2%) 572 (55.6%) 1026 (49.3%) 464 (40.2%)
7–11 416 (39.6%) 156 (27.2%) 171 (29.4%) 312 (30.3%) 728 (35.0%) 327 (28.3%)
12+ 181 (17.2%) 327 (56.9%) 37 (6.4%) 145 (14.1%) 326 (15.7%) 364 (31.5%)
Socioeconomic status
Lowest tertile 127 (12.1%) 135 (23.5%) 419 (72.1%) 356 (34.6%) 483 (23.2%) 554 (48.0%)
Middle tertile 387 (36.8%) 156 (27.2%) 147 (25.3%) 401 (38.9%) 788 (37.9%) 303 (26.2%)
Highest tertile 538 (51.1%) 283 (49.3%) 15 (2.6%) 273 (26.5%) 811 (38.9%) 298 (25.8%)
Lifestyle behaviours, n (%)
Daily smoking 34 (3.2%) 12 (2.1%) 1 (0.2%) 56 (5.4%) 90 (4.3%) 13 (1.1%)
Heavy alcohol drinking 57 (5.4%) 35 (6.1%) 16 (2.8%) 59 (5.7%) 116 (5.6%) 51 (4.4%)
TV watching (2+ hour/day) 509 (48.4%) 265 (46.2%) 83 (14.3%) 525 (51.0%) 1034 (49.7%) 348 (30.2%)
Leisure-time inactivity 974 (92.6%) 518 (90.2%) 558 (96.0%) 978 (95.0%) 1952 (93.8%) 1076 (93.2%)
Transport-related inactivity 75 (7.1%) 19 (3.3%) 12 (2.1%) 216 (21.0%) 291 (14.0%) 31 (2.7%)
Fried food consumption
Weekly/daily 686 (65.2%) 427 (74.4%) 427 (73.5%) 684 (66.4%) 1370 (65.8%) 854 (73.9%)
High-sugar beverages consumption
Weekly/daily 665 (63.2%) 301 (52.4%) 296 (51.0%) 409 (39.7%) 1074 (51.6%) 597 (51.7%)
Measurements, n (%)
Body mass index (kg/m2)
Normal (<25 kg/m2) 243 (23.2%) 135 (24.0%) 316 (54.5%) 255 (24.8%) 498 (24.0%) 451 (39.5%)
Overweight (≥25 and <30 kg/m2) 471 (45.0%) 278 (49.4%) 205 (35.3%) 450 (43.6%) 921 (44.4%) 483 (42.3%)
Obese (≥30 kg/m2) 332 (31.7%) 150 (26.6%) 59 (10.2%) 325 (31.6%) 657 (31.6%) 209 (18.3%)
Central obesity (IDF) 787 (75.2%) 428 (76.0%) 277 (47.8%) 845 (82.1%) 1632 (78.7%) 705 (61.7%)
Total cholesterol (≥200 mg/dL) 499 (48.4%) 250 (48.6%) 174 (32.3%) 539 (52.3%) 1038 (50.4%) 424 (40.3%)
Metabolic syndrome 505 (49.9%) 246 (47.9%) 150 (27.8%) 563 (54.7%) 1068 (51.8%) 396 (37.6%)
Hypertension 212 (20.2%) 79 (13.8%) 72 (12.4%) 277 (26.9%) 489 (23.5%) 151 (13.1%)
Type 2 diabetes mellitus 57 (5.5%) 37 (7.2%) 17 (3.2%) 106 (10.3%) 163 (7.9%) 54 (5.1%)
Results may not add due to missing values. IDF, International Diabetes Federation.
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Determinants of SBP and DBP changes over time
In multivariable model, study site was a strong predictor of SBP
and DBP changes over time (p<0.001); however, impact of
urbanisation was not uniform ranging from −3.73 mm Hg in
urban Puno to 4.76 mm Hg in semiurban Tumbes in the case of
SBP compared with highly urbanised Lima (table 3). On the
other hand, site altitude only modiﬁed SBP but not DBP over
time. Among modiﬁable risk factors, heavy alcohol drinking
(p<0.001) and high-sugar beverage consumption (p<0.001)
increased both SBP and DBP during follow-up. All the
anthropometric measurements and laboratory markers increased
SBP and DBP across follow-up rounds.
DISCUSSION
Individuals from semiurban sites were at higher risk compared
with those from urbanised and rural sites. Moreover, the risk of
hypertension was lower in high-altitude sites. Prehypertension
and obesity were the leading risk factors for developing hyper-
tension in all the study sites, but estimates, mainly in the case of
obesity, varied depending on site’s characteristics. Therefore, the
results from this study can appropriately inform prevention and
monitoring efforts including the identiﬁcation of hot spot areas.
While the incidence of hypertension was similar between
highly urbanised, urbanised and rural sites in the multivariable
model, semiurban areas were at greater risk of hypertension
introducing the need for further scrutiny to explain these
results. Thus, according to PAF, leisure-time physical inactivity
appears to be a problem in urban Puno and semiurban Tumbes
(PAF >30%) but not in the other sites, whereas the effect of
obesity was lower in urban Puno (PAF 12.5%) but high in the
other sites (PAF ≥30%). The site in Tumbes, in the northern
coast of Peru, is comprised by a group of communities with
Table 2 Association between study site characteristics and the risk of hypertension: crude and adjusted models
Adjusted models
Incidence (95% CI) Crude model Model 1 Model 2 Model 3
Per 100 person-years IRR (95% CI) IRR (95% CI) IRR (95% CI) IRR (95% CI)
Study site
Lima 5.91 (4.92–7.10) 1 (reference) 1 (reference) 1 (reference) 1 (reference)
Urban Puno 5.73 (4.33–7.59) 0.98 (0.71–1.34) 1.01 (0.71–1.43) 1.01 (0.72–1.44) 1.02 (0.72–1.45)
Rural Puno 5.19 (3.76–7.16) 0.88 (0.62–1.26) 0.80 (0.55–1.16) 0.83 (0.57–1.21) 0.99 (0.68–1.45)
Tumbes 9.88 (8.52–11.5) 1.67 (1.34–2.08) 1.75 (1.39–2.19) 1.79 (1.41–2.26) 1.76 (1.39–2.23)
Site altitude
Low 7.81 (6.96–8.77) 1 (reference) 1 (reference) 1 (reference) 1 (reference)
High 5.49 (4.44–6.78) 0.71 (0.56–0.89) 0.65 (0.51–0.82) 0.67 (0.52–0.85) 0.74 (0.58–0.95)
Bold estimates are statistically significant (p<0.05).
Model 1 was adjusted by sex, age, education level and socioeconomic status.
Model 2 was adjusted for sex, age, education level, socioeconomic status, daily smoking, heavy alcohol drinking, TV watching for 2+ hours per day, transport-related physical inactivity,
fried food consumption and high-sugar beverage consumption.
Model 3 was adjusted for sex, age, education level, socioeconomic status, daily smoking, heavy alcohol drinking, TV watching for 2+ hours per day, transport-related physical inactivity,
fried food consumption and high-sugar beverage consumption, body mass index and type 2 diabetes mellitus.
IRR, incidence rate ratios.
Figure 1 Modiﬁable factors and the risk of hypertension: adjusted models and population-attributable fractions (PAFs). *The model was adjusted
by sex, age, education level, socioeconomic status and study site. IRR, incidence rate ratio.
4 Bernabé-Ortiz A, et al. Heart 2017;0:1–7. doi:10.1136/heartjnl-2016-310347
Special populations
about 20 000 people spread over 80 km2, where the traditional
agricultural landscape has become intermixed with rapidly
growing urban sections. Thus, it seems that LMIC societal
changes associated with growth and urbanisation are being tele-
scoped into a much briefer time period relative to the lifespan
of individuals.19
Individuals from high-altitude sites had reduced hypertension
incidence rates compared with low-altitude sites. Individuals
from high-altitude areas had greater PAF related to physical
inactivity, fried food and high-sugar beverage consumption; PAF
of obesity, however, was lower compared with low-altitude sites.
These results support the fact that changes towards unhealthy
diet and physical activity patterns are not homogeneous within
country.20 21 Previous reports, cross-sectional in nature, have
shown divergent results. For example, a systematic review ana-
lysed different cross-sectional surveys from Tibet and suggested
a positive correlation between altitude and the prevalence of
hypertension.22 Conversely, lower rates of hypertension have
been observed in individuals from high-altitude rural areas of
Nepal.23 There is evidence that blood pressure does not vary in
response to short-term hypoxic exposure;24 and increased blood
pressure during altitude adaptation is explained by sympathetic
nervous system activation.25 Permanent residence at high alti-
tudes is associated with decrease in both SBP and DBP, perhaps
secondary to chronic hypoxaemia. However, there is limited
information about the physiological mechanisms of long-term
exposure to high altitude and hypertension. Therefore, our
study expands on previous ﬁndings by demonstrating the longi-
tudinal impact of the environment and high altitude on the
development of hypertension.
Among all the modiﬁable risk factors assessed in this study,
only heavy alcohol drinking was associated with developing
hypertension. Although alcohol has shown some beneﬁcial
effects on cardiovascular outcomes, heavy drinking increases the
risk of hypertension as in previous studies,26 27 yet its PAF was
<5% in our population. Clinical variables such as high total
cholesterol, metabolic syndrome and type 2 diabetes increased
the risk of hypertension as previous studies have shown.28 29
When using PAF, two different factors explained a high pro-
portion of new cases of hypertension: obesity and prehyperten-
sion. Obesity was one of the leading risk factors for developing
hypertension. The same pattern was observed in all the study
sites and conﬁrmed by the mixed-effect model. However, there
was a great variation in the PAF estimates according to study
site, thus conﬁrming that the population-level effect of obesity
on hypertension in each site is not uniform. Prehypertension
was present in almost a quarter of the overall study population
at baseline and was more frequent in semiurban sites (data not
shown).5 Moreover, according to PAF, hypertension would be
reduced by almost 40% in the study population if a reduction
of blood pressure under 120/80 mm Hg were guaranteed,
reinforcing the need for active screening of blood pressure levels
or primary prevention strategies to avoid progression towards
hypertension.
We report an overall hypertension incidence of 7 per 100
person-years. Our incidence estimates are similar to those
reported for African-Americans in the USA, a population group
that has been well characterised to have higher incidence rates
relative to white subjects.30 Under these circumstances, our ﬁnd-
ings are worrying because they suggest our population could
Table 3 Systolic and diastolic blood pressure variation over time and associated factors: crude and adjusted linear mixed-effect models
Systolic blood pressure (mm Hg) Diastolic blood pressure (mm Hg)
Crude model Adjusted model Crude model Adjusted model
β (95% CI) β (95% CI) β (95% CI) β (95% CI)
Sociodemographic variables*
Study site (vs Lima)
Urban Puno −3.35 (−4.65 to −2.06) −3.61 (−4.85 to −2.36) 0.67 (−0.18 to 1.52) 0.37 (−0.51 to 1.25)
Rural Puno −0.99 (−2.25 to 0.26) −1.48 (−2.76 to −0.21) 3.24 (2.45 to 4.03) 3.47 (2.59 to 4.36)
Tumbes 4.60 (3.39 to 5.80) 4.74 (3.63 to 5.85) 2.94 (2.20 to 3.68) 2.94 (2.20 to 3.69)
Site altitude (vs low)
High altitude −4.33 (−5.26 to −3.40) −5.03 (−5.91 to −4.15) 0.58 (−0.01 to 1.18) 0.40 (−0.22 to 1.01)
Lifestyle behaviours†
Daily smoking 1.39 (−0.85 to 3.64) −1.32 (−3.26 to 0.61) 1.05 (−0.43 to 2.53) −0.56 (−2.01 to 0.90)
Heavy alcohol drinking 5.02 (3.21 to 6.84) 3.05 (1.41 to 4.68) 3.53 (2.37 to 4.69) 1.91 (0.75 to 3.07)
TV watching for 2+ hours per day 0.22 (−0.73 to 1.17) 0.07 (−0.79 to 0.93) 0.22 (−0.37 to 0.81) 0.27 (−0.31 to 0.85)
Leisure-time physical inactivity −1.89 (−3.58 to −0.21) −1.44 (−3.05 to 0.17) −1.68 (−2.75 to −0.61) −1.01 (−2.09 to 0.06)
Transport-related physical inactivity 2.59 (0.75 to 4.43) −0.55 (−2.15 to 1.05) 0.08 (−0.93 to 1.09) −0.38 (−1.38 to 0.62)
Fried food consumption −0.42 (−1.46 to 0.62) 0.26 (−0.64 to 1.16) 0.49 (−0.15 to 1.14) 0.23 (−0.37 to 0.84)
High-sugar beverage consumption 0.83 (−0.11 to 1.78) 1.06 (0.21 to 1.90) 1.20 (0.62 to 1.78) 1.05 (0.47 to 1.62)
Measurements†
Body mass index (vs normal)
Overweight (≥25 and <30 kg/m2) 1.83 (0.73 to 2.93) 3.45 (2.48 to 4.41) 1.68 (1.00 to 2.37) 2.49 (1.82 to 3.16)
Obese (≥30 kg/m2) 3.22 (1.93 to 4.50) 5.72 (4.55 to 6.88) 3.33 (2.54 to 4.12) 5.11 (4.31 to 5.91)
Central obesity (IDF) 1.58 (0.57 to 2.59) 3.96 (3.03 to 4.89) 1.44 (0.80 to 2.08) 3.08 (2.43 to 3.73)
Total cholesterol ≥200 mg/dL 2.82 (1.87 to 3.77) 2.82 (1.98 to 3.65) 1.61 (1.02 to 2.20) 1.91 (1.34 to 2.47)
Metabolic syndrome 4.54 (3.57 to 5.50) 4.79 (3.95 to 5.64) 2.74 (2.14 to 3.34) 3.32 (2.75 to 3.89)
Type 2 diabetes mellitus 4.07 (2.02 to 6.12) 2.81 (0.80 to 4.81) 1.15 (−0.11 to 2.41) 1.53 (0.26 to 2.81)
Bold estimates are statistically significant (p<0.05).
*Each variable was adjusted by sex, age, education level, socioeconomic status and time of follow-up.
†Each variable was adjusted by sex, age, education level, socioeconomic status, study site and time of follow-up.
Bernabé-Ortiz A, et al. Heart 2017;0:1–7. doi:10.1136/heartjnl-2016-310347 5
Special populations
face the same disadvantages, in terms of cardiovascular health,
as those faced by African-Americans. Our understanding of
intervention strategies for non-communicable diseases in
resource-poor settings is limited, if not absent, a disquieting fact
given the trends of rise in SBP in many LMICs.31 The complex
context of LMIC can provide a variety of scenarios that could
identify new areas for innovation, relevant both at local and
international levels, including Hispanic and Latino
populations.32 33
Our results lend support to actions where interventions
designed to tackle hypertension could well be focused on
obesity but through different pathways. For this, strategies
should be implemented to promote mainly physical activity
especially in the areas transitioning towards greater urbanisation,
that is, urban and semiurban settings. In contrast, in rural areas,
the focus of those interventions should be centred on securing
patterns of healthy eating, mainly addressing reductions in the
consumption of fried foods and sugar-added beverages.
This is a longitudinal study assessing the progression towards
hypertension in different study sites with varying degree of
urbanisation and altitude in an LMIC. Our estimates were calcu-
lated using a population-based study and standardised techni-
ques. Nevertheless, some limitations should be considered. First,
study site was used as a proxy of urbanisation process and alti-
tude, and, for instance, some other unmeasured characteristics,
that is, ethnicity, race, genetics, and so on, might have an impact
on our results. For example, Quechua and Aymara groups are
more frequent in highlands, especially in rural areas. Therefore,
other prospective studies in other settings are required to
corroborate our ﬁndings. Second, although we enrolled >3000
participants, statistical power might be an issue as well-
recognised factors were not signiﬁcant, perhaps because of
short-term follow-up (30 months). However, as PAF assesses the
contribution of a risk factor to a disease, they can provide a
better understanding of the role of these factors in the involved
populations. Third, some bias may arise as rejection rate at
enrolment was different among study sites, being lower in semi-
urban Tumbes compared with the other sites (data not shown).
Fourth, ambulatory blood pressure, considered the
state-of-the-art way to assess hypertension, was not available,
and instead only ofﬁce blood pressure was used. Finally,
although several variables were included in multivariable model,
results may reﬂect the effect of unmeasured confounders. Diet
and physical activity patterns were not completely assessed as
only patterns of fried food and high-sugar beverage consump-
tion and two domains of the IPAQ were included.
Our results are compatible with within-country heterogeneity
in the developing of hypertension in resource-limited settings,
lending support for focused and context-speciﬁc target interven-
tions to reduce and tackle the burden of raised blood pressure
for large populations. Obesity, assessed as body mass index and
waist circumference, was the leading factor for developing
hypertension in all the study sites. The development and imple-
mentation of interventions designed to address elevated blood
pressure would beneﬁt from accounting by geographical
characteristics of low-income settings such as urbanisation and
altitude.
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